Hologic Must Make The Third Time A Charm

By Ted Stamas:Hologic (HOLX) is a high-profile company in women's healthcare needs. In fact, it is the goodwill ambasador for the sector. Its four operating segments break down to: Breast Health (45%), Diagnostics (33%), GYN Surgical (17%), and, Skeletal Health (5%) -- a significant body of work.

By Stephen Simpson:Big deals carry big risks, and Hologic (HOLX) does not have a great record with big deals. Couple that with a difficult hospital spending environment and I can understand why Hologic shares trade at a discount to fair value. That said, investors who want to buy into women's health and diagnostics could certainly do worse than to consider this name. Fiscal Third Quarter Results In Line With Warning

Ted Stamas submits:According to the U.S. National Cancer Institute, one in eight women will be diagnosed with breast cancer sometime during their lifetime. It's a big issue because breast cancer tends to be an aggressive form of oncology and unless it is detected early, your survival rate is slim.

By Matthew Frankel:Hologic (HOLX) is set to report earnings on Monday, and I believe this creates a great opportunity to attempt to buy the stock for a discount. This innovative company deserves to be owned, and is undervalued at current levels. However, for those who may not be too familiar with what they are and what they do, let's examine the fundamentals.

Hologic (HOLX) Q1 2011 Earnings Call January 31, 2011 5:00 pm ET Executives Steven Williamson - Senior Vice President and General Manager of GYN Surgical Products Robert Cascella - Chief Executive Officer, President and Director David Harding - Glenn Muir - Chief Financial Officer, Executive Vice President of Finance & Administration, Treasurer and Director Deborah Gordon - Vice President of Investor Relations

Hologic (HOLX) Q1 2012 Earnings Call January 30, 2012 5:00 pm ET Executives Deborah R. Gordon - Vice President of Investor Relations Robert A. Cascella - Chief Executive Officer, President and Director Glenn P. Muir - Chief Financial Officer, Executive Vice President of Finance & Administration and Director David P. Harding - Senior Vice President and General Manager of International

Hologic (HOLX) Q3 2011 Earnings Call August 01, 2011 5:00 pm ET Executives Steven Williamson - Senior Vice President and General Manager of GYN Surgical Products Robert Cascella - Chief Executive Officer, President and Director Peter Soltani - Senior Vice President and General Manager of Breast Health David Harding - Senior Vice President and General Manager of International

Hologic (HOLX) Q2 2011 Earnings Call May 02, 2011 5:00 pm ET Executives Steven Williamson - Senior Vice President and General Manager of GYN Surgical Products Robert Cascella - Chief Executive Officer, President and Director David Harding - Senior Vice President and General Manager of International Glenn Muir - Chief Financial Officer, Executive Vice President of Finance & Administration, Treasurer and Director